| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2993741 | Journal of Vascular Surgery | 2010 | 7 Pages |
Abstract
Protamine reduced serious bleeding requiring reoperation during CEA without increasing the risk of MI, stroke, or death, in this large, contemporary registry. In light of significant complications referable to bleeding, liberal use of protamine during CEA appears warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David H. MD, Brian W. MD, Andres MD, Philip P. MD, Robert A. MD, Donald S. PhD, Daniel B. MD, Jack L. MD, Vascular Study Group of Northern New England Vascular Study Group of Northern New England,